Table 3.
Hypertension Prevalence by Sex, Age, Race/Ethnicity, and Comorbidity Status Category, Among Adults Aged 18 Years and Older With a Primary Healthcare Visit Within the Past Year—NHANES, 1999–2012
| Age, y | Race/Ethnicity | Number of Comorbidities | Hypertension Prevalence (95% CI) | |
|---|---|---|---|---|
| Men | Women | |||
| 18–44 | Non‐Hispanic white | 0 | 8.4 (7.1–9.9) | 3.5 (2.6–4.8) |
| 1 | 21.1 (17.8–24.7) | 11.6 (9.3–14.4) | ||
| 2–3 | 38.2 (26.2–51.7) | 37.3 (28.1–47.5) | ||
| Non‐Hispanic black | 0 | 10.0 (8.0–12.4) | 9.3 (7.3–11.9) | |
| 1 | 27.8 (23.1–33.1) | 17.3 (14.7–20.3) | ||
| 2–3 | 64.8 (51.5–76.1) | 52.2 (41.6–62.6) | ||
| Hispanica | 0 | 5.2 (3.6–7.4) | 1.7 (0.9–3.3) | |
| 1 | 13.9 (10.2–18.7) | 7.9 (5.3–11.8) | ||
| 2–3 | 54.6 (42.6–66.1) | 24.7 (15.8–36.4) | ||
| Other | 0 | 8.9 (5.2–14.7) | 3.4 (1.8–6.3) | |
| 1 | 25.9 (17.2–37.2) | 12.4 (6.2–23.3) | ||
| 2–3 | 43.1 (13.7–78.4) | 25.1 (8.5–54.6) | ||
| Missing/Totalb | 0 | 8.2 (7.2–9.2) | 3.8 (3.1–4.7) | |
| 1 | 21.1 (18.6–23.9) | 12.1 (10.5–14.0) | ||
| 2–3 | 46.5 (38.3–55.0) | 37.5 (31.4–43.9) | ||
| 45–64 | Non‐Hispanic white | 0 | 32.3 (28.6–36.3) | 26.8 (24.0–29.7) |
| 1 | 46.9 (42.7–51.1) | 49.2 (44.8–53.6) | ||
| 2–3 | 70.9 (65.4–75.8) | 67.3 (59.5–74.2) | ||
| Non‐Hispanic black | 0 | 46.1 (41.4–50.8) | 45.9 (40.3–51.7) | |
| 1 | 60.0 (53.6–66.1) | 66.4 (61.7–70.9) | ||
| 2–3 | 87.0 (81.1–91.3) | 86.1 (81.9–89.4) | ||
| Hispanica | 0 | 26.3 (20.8–32.7) | 23.9 (18.6–30.3) | |
| 1 | 44.0 (35.5–52.8) | 38.3 (32.7–44.2) | ||
| 2–3 | 64.5 (53.3–74.2) | 67.6 (60.0–74.4) | ||
| Other | 0 | 31.3 (21.4–43.2) | 28.0 (20.0–37.7) | |
| 1 | 50.1 (35.8–64.4) | 58.7 (45.9–70.5) | ||
| 2–3 | 68.8 (39.2–88.3) | 65.9 (45.2–81.9) | ||
| Missing/Totalb | 0 | 32.9 (29.8–36.3) | 27.9 (25.6–30.3) | |
| 1 | 48.1 (44.6–51.7) | 50.9 (47.5–54.4) | ||
| 2–3 | 72.4 (68.4–76.0) | 71.3 (66.5–75.7) | ||
| 65–74 | Non‐Hispanic white | 0 | 51.9 (46.4–57.4) | 55.3 (50.4–60.2) |
| 1 | 64.2 (58.6–69.4) | 68.8 (63.4–73.7) | ||
| 2–3 | 77.0 (69.5–83.1) | 90.0 (84.8–93.5) | ||
| Non‐Hispanic black | 0 | 71.5 (62.9–78.8) | 69.7 (57.9–79.3) | |
| 1 | 80.9 (72.9–87.0) | 88.0 (82.2–92.0) | ||
| 2–3 | 86.1 (79.6–90.7) | 92.1 (86.9–95.4) | ||
| Hispanica | 0 | 41.1 (29.8–53.3) | 65.3 (53.1–75.8) | |
| 1 | 63.8 (50.4–75.3) | 75.8 (64.2–84.5) | ||
| 2–3 | 74.5 (59.9–85.2) | 84.5 (73.9–91.3) | ||
| Other | 0 | 68.5 (47.4–84.0) | 48.5 (30.7–66.6) | |
| 1 | 62.1 (37.9–81.5) | 92.0 (76.9–97.5) | ||
| 2–3 | 80.2 (49.7–94.3) | 93.5 (64.0–99.1) | ||
| Missing/Totalb | 0 | 53.1 (48.4–57.8) | 56.3 (52.0–60.6) | |
| 1 | 65.4 (60.7–69.9) | 71.8 (67.3–75.9) | ||
| 2–3 | 77.9 (71.9–82.8) | 90.0 (86.2–92.8) | ||
| ≥75c | Non‐Hispanic white | 0 | 58.2 (53.3–63.0) | 69.3 (64.2–74.0) |
| 1 | 71.2 (67.1–75.0) | 82.5 (79.2–85.3) | ||
| 2–3 | 77.5 (71.9–82.2) | 87.5 (83.6–90.6) | ||
| Non‐Hispanic black | 0 | 68.8 (54.1–80.4) | 85.6 (70.5–93.7) | |
| 1 | 89.8 (79.3–95.3) | 84.1 (73.8–90.9) | ||
| 2–3 | 81.3 (69.3–89.3) | 93.8 (87.3–97.1) | ||
| Hispanica | 0 | 61.2 (48.1–72.9) | 74.3 (55.4–87.0) | |
| 1 | 73.0 (61.3–82.1) | 88.5 (80.6–93.4) | ||
| 2–3 | 89.0 (76.5–95.3) | 75.3 (61.5–85.4) | ||
| Other | 0 | 34.6 (11.8–67.7) | 80.6 (49.7–94.6) | |
| 1 | 68.4 (47.0–84.0) | 83.1 (62.6–93.5) | ||
| 2–3 | 58.8 (29.8–82.8) | 85.2 (62.0–95.3) | ||
| Missing/Totalb | 0 | 58.5 (54.0–62.8) | 70.6 (65.8–74.9) | |
| 1 | 72.2 (68.4–75.6) | 82.8 (79.9–85.4) | ||
| 2–3 | 77.6 (72.7–81.9) | 87.7 (84.3–90.3) | ||
Abbreviations: CI, confidence interval; NHANES, National Health and Nutrition Examination Survey. aPrior to 2007, NHANES only reported data specific to Mexican Americans; other Hispanics were included in the “Other” race/ethnicity category and are not able to be differentiated. For these purposes, Mexican Americans were considered to represent all Hispanics during 1999–2006. bAdded to accommodate those health systems that are unable to report their data by race/ethnicity or who may have some patients who lack a race/ethnicity classification. The hypertension prevalence estimate for all race‐ethnicities, by comorbidity status, is applied to this category. cAn age cap of 85 years is used in the Estimator Tool to better align with the clinical quality measures health systems are already reporting. However, NHANES codes all participants aged 80 years and older as being aged 80 years for confidentially reasons; therefore, some of the participants used to compute the hypertension prevalence estimates for those aged 75 to 85 years are older than age 85.